1. Home
  2. ONON vs NBIX Comparison

ONON vs NBIX Comparison

Compare ONON & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo On Holding AG

ONON

On Holding AG

HOLD

Current Price

$34.69

Market Cap

15.3B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$132.70

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONON
NBIX
Founded
2010
1992
Country
Switzerland
United States
Employees
N/A
2000
Industry
Shoe Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
13.2B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
ONON
NBIX
Price
$34.69
$132.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
21
22
Target Price
$60.14
$175.27
AVG Volume (30 Days)
7.7M
810.0K
Earning Date
03-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
N/A
4.67
Revenue
N/A
$161,626,000.00
Revenue This Year
$19.24
$22.85
Revenue Next Year
$19.81
$10.36
P/E Ratio
$56.05
$28.20
Revenue Growth
N/A
977.51
52 Week Low
$31.41
$84.23
52 Week High
$61.29
$160.18

Technical Indicators

Market Signals
Indicator
ONON
NBIX
Relative Strength Index (RSI) 36.80 54.02
Support Level $34.38 $128.03
Resistance Level $44.10 $136.74
Average True Range (ATR) 1.61 3.27
MACD -0.35 0.47
Stochastic Oscillator 35.79 80.18

Price Performance

Historical Comparison
ONON
NBIX

About ONON On Holding AG

On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: